Advanced Biomed (ADVB) EPS (Weighted Average and Diluted) (2023 - 2026)

Advanced Biomed has disclosed EPS (Weighted Average and Diluted) across 4 years of filings, most recently posting -$0.38 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.38, up 71.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.29 (up 257.93% YoY), and the FY2025 annual result was -$0.16, down 14.29% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.38 for Q1 2026 at Advanced Biomed, down from $0.31 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.38 in Q2 2025 to a low of -$1.35 in Q1 2025.
• The 4-year median for EPS (Weighted Average and Diluted) is -$0.03 (2024), against an average of $0.08.
• Peak annual rise in EPS (Weighted Average and Diluted) reached 6050.0% in 2025, while the deepest fall reached 2600.0% in 2025.
• Advanced Biomed's EPS (Weighted Average and Diluted) stood at -$0.01 in 2023, then plunged by 400.0% to -$0.05 in 2024, then soared by 720.0% to $0.31 in 2025, then plunged by 222.58% to -$0.38 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.38 (Q1 2026), $0.31 (Q4 2025), and -$0.02 (Q3 2025), per Business Quant data.